Atrioventricular Canal Defect: Causes, Symptoms, Treatment & Prevention

Atrioventricular canal defect (AV canal, atrioventricular septal defect, AVSD) results from defective fusion of endocardial cushions that normally partition the atrioventricular canal into separate right- and left-sided atrioventricular inlets and scaffold the developing AV valves. Depending on lesion extent, the malformation may include a primum atrial septal component, inlet ventricular septal components, and a common AV valve annulus with variable bridging leaflets—physiologically producing left-to-right shunting at atrial and/or ventricular level plus regurgitation across abnormal AV valve tissue.

Haemodynamically, large shunts raise pulmonary blood flow and predispose infants to congestive symptoms as pulmonary circulation becomes overloaded; significant AV valve regurgitation adds volume load to both ventricles and can accelerate failure. Without timely surgery in complete forms, chronically elevated pulmonary flow risks fixed pulmonary vascular disease—a threshold that changes candidacy and hazard for repair. Partial variants share the principle of AV valve malformation with shunting but may impose a milder circuit depending on septal commitment and regurgitation grade.

For nursing and allied teams the operational framing is not embryology recall but recognition of high-output congestive patterns in infancy, accurate intake and weight trending, meticulous vital acquisition during feeds or distress, and anticipatory coordination with cardiology around echo surveillance, medication weaning, and perioperative transitions.

Classification systems centre on whether separate right- and left-sided AV valve orifices exist and how much inlet ventricular septum remains between ventricular chambers—language varies between centres, but bedside teams should map patients to partial / transitional / complete buckets because management timelines diverge.

↔On a small screen, swipe or scroll sideways to see the full table.

Exact anatomic labels on echo reports supersede ward shorthand—when uncertain, ask cardiology fellows for a one-line diagram in the notes.

Infancy (especially complete AVSD): Tachypnoea, subcostal and intercostal retractions, feeding lasting longer than peers with sweating at the bottle or breast, poor weight velocity, irritability when flat, and sometimes recurrent lower respiratory symptoms from congested lung fields. A harsh pansystolic murmur at the left sternal border often prompts screening chest radiograph before echocardiographic confirmation.

Partial / milder transitional lesions: May remain relatively compensated for weeks to months with subtler tachypnoea or incident murmur detection at routine checks—still expect eventual referral if AV regurgitation or shunt volume rises.

Atypical cues: Neonates can masquerade as “feeder-grower” problems alone; any rapid resting heart rate with poor caloric success should trigger cardiology safety-netting even before cyanosis appears.

Embryology: Failed or delayed fusion of endocardial cushion tissue disturbs the atrioventricular septum and valve apparatus—producing the spectrum from ostium primum ASD physiology to complete common AV valve defects.

Genetics / syndromes: Trisomy 21 is the archetypal association; other chromosomal anomalies occur less frequently. A positive antenatal genetic screen should heighten suspicion for major CHD including AVSD.

Maternal and environmental contributors: Broader CHD literature implicates poorly controlled diabetes, certain teratogens, rubella where vaccination coverage is incomplete, and familial CHD—follow perinatal history documentation standards and refer to maternal–fetal medicine when antenatal risk markers appear.

Clinical assessment

Structured vital signs before, during, and after feeds; plotting weights; checking preductal/postductal saturations when neonatal hypoxia is questioned; and quantifying work of breathing form the ward dataset cardiologists trust when interpreting evolving lesions.

Laboratory investigations

Baseline labs may include FBC (cyanotic episodes, syndromic polycythaemia nuances), electrolytes when diuretics commence, and NT-proBNP variants if your centre uses biomarkers—interpret only within local pathways.

Imaging

Chest X-ray often shows cardiomegaly with increased pulmonary vascular markings in significant shunts—useful for triage but not definitive. Echocardiography delineates ASD and VSD commitment, chordal anatomy, AV regurgitation severity, and estimated pulmonary artery pressures; fetal echocardiography may diagnose antenatally in tertiary programmes.

Criteria / severity anchors used in practice

Surgical candidacy integrates symptom burden, weight gain, Doppler-estimated pulmonary pressures, and AV valve repairability—decisions are surgeon- and centre-specific rather than a single numeric rule.

1. Detect: Screening murmur, antenatal echo flag, or infant congestive signs → arrange paediatric cardiology and echo urgency per severity.
2. Stabilise: If feeding-safe, support nutrition (often fortified feeds or NG supplementation per dietetics); initiate diuretic bridges only when prescribed; monitor electrolytes.
3. Define anatomy: Echo clarifies partial versus complete architecture and quantifies AV regurgitation—document leaflets and chordae description in handoffs.
4. Plan repair: Elective surgical slots balance pulmonary vascular protection with growth—recognise that undue delay risks fixed pulmonary hypertension.
5. Postoperative: PICU step-down focuses on cardiac output, arrhythmia monitoring, and valve competency; community nurses continue wound, calorie, and medication reconciliation.

• Large muscular or perimembranous VSD without common AV valve—different apical/inlet echo signature.
• Isolated ostium primum ASD (rare without cleft AV valve phenomena)—still warrants expert echo for subtle AVSD.
• Secundum ASD—natural history generally distinct from AV canal physiology.
• TAPVR / obstructed lesions when cyanosis dominates early neonatal hours—different saturations trajectory.
• Primary pulmonary pathology (RDS, pneumonia) without structural shunt—CXR and echo separate diagnoses.

First-line management

Surgical repair remains definitive for symptomatic complete AVSD and most partial forms with notable regurgitation or shunt-related failure. Operations reconstruct AV septal components and partition common valve tissue into separate neovalves; timing balances growth with pulmonary vascular risk.

Medical therapy before surgery

Clinicians often prescribe loop diuretics and sometimes afterload strategies depending on programme; digoxin appears in selected infants—teach families strict dosing and toxicity vigilance. ACE inhibitors may be used per team—never start or adjust without cardiology direction.

Adjunct supports

Oxygen does not fix left-to-right shunt physiology but may be ordered transiently for perioperative or coexistent lung issues—follow SpO₂ targets on the prescription.

Special populations

Trisomy 21: Plan airway management in collaboration with anaesthesia; expect different pulmonary hypertension pharmacology discussions if late presenters emerge. Prematurity: Nutritional and timing trade-offs need MDT alignment.

Operational cadence hinges on predictable echo-to-bedside feedback loops:

• Weekly (or tighter) weight checks during symptomatic shunt physiology; plot on WHO or programme growth charts.
• Reassess diuretic needs after acute illnesses, or if vomiting/diarrhoea threatens prerenal injury—communicate gaps to prescribers.
• Review feeding plan after each cardiology visit—fortification changes frequently preoperatively.
• Before surgery, complete pre-anesthesia checklists, allergy review, and dental hygiene counselling if age-appropriate (future endocarditis conversations).
• Post-repair, continue rhythm awareness for the first weeks—palpitations in older repaired adolescents still merit ECG.

Short term: Low cardiac output after repair, AV valve regurgitation recurrence, junctional ectopic tachycardia or heart block, pleural effusions, feeding aversion. Medium-to-long term: Residual valve incompetence needing reoperation, subpulmonary stenosis variants, late arrhythmias, endocarditis, and developmental or exercise limitation if output remains borderline.

Pulmonary vascular disease remains the dominant failure mode when diagnosis or surgery is delayed—anticipate multidisciplinary discourse on pulmonary vasodilators only within specialist centres.

AVSD is not preventable in the consumer “lifestyle” sense—clinician-facing prevention means antenatal diagnosis where ultrasound programmes permit, periconception folic acid strategies aligned with WHO public health guidance for neural tube and broader birth-defect risk reduction, rubella immunity before pregnancy, and tight glycaemic control for diabetes complicating pregnancy. Newborn screening programmes for critical congenital heart disease vary by jurisdiction—follow local protocols (CDC CHD hub summarises population programmes)—while remembering pulse oximetry misses many left-to-right shunts until symptoms declare.

With modern infant repair in experienced programmes, many children reach school age with acceptable valve function; nevertheless lifelong cardiology follow-up is standard because reintervention rates for residual regurgitation or subaortic obstruction are not negligible. Prognosis worsens if irreversible pulmonary hypertension develops preoperatively—highlighting the nursing role in ensuring families attend timed reviews and escalate deteriorations early.

• Record feed duration, pauses, and calories—cardiologists weight these as heavily as auscultation findings.
• Use developmentally sensitive distraction for echo preparedness; recognise sensory needs in trisomy 21.
• Translate diuretic schedules into plain-language charts for grandparents or rotating carers—missed doses alter congestion faster than families expect.
• Flag signs of digoxin toxicity (vomiting, bradycardia, lethargy) if the medication is prescribed—cross-check agency monographs and urgent prescriber thresholds.
• Rehearse transport to tertiary centre plans with parents before labour if fetal diagnosis exists.

• Respiratory: RR, retractions, nasal flare, feeding-associated tachypnoea, oxygen requirement per prescription.
• Cardiovascular: HR trend, capillary refill, pulses, blood pressure limb discrepancy if arch anomalies coexist.
• Nutrition: Daily weights when unstable, weekly when stable but pre-surgical; emesis accounting.
• Drug monitoring: Electrolytes when on loop diuretics; watch renal function if diarrhoeal illness supervenes.
• Family stress: Screen caregiver sleep deprivation—unsafe home situations slow adherence.

• Respiratory failure—silent chest with exhaustion, apnoeas, or SpO₂ sustained below target despite escalation.
• Circulatory collapse, non-blanching rash with sepsis concern, or unrousable child.
• Suspected arrhythmia with syncope, sudden pallor, or HR extremes on monitor.
• Acute neurological change suggesting stroke or hypoperfusion.

While awaiting retrieval: position per comfort, deliver prescribed oxygen or NIV only within scope, maintain normothermia, and pass a structured handoff including last echo summary if available.

Red-flag symptom clusters

• Escalating work of breathing over 24–48 h despite adherence to medications and feeds.
• Weight loss crossing two centile channels or negative weekly trend preoperatively.
• New central cyanosis or falling SpO₂ in a previously “pink” shunt patient.

Objective bedside cues

• Tachycardia out of proportion to temperature, poor perfusion, rising lactate, or narrowing pulse pressure.
• Hepatomegaly progression or new gallop rhythm on auscultation.

Escalation ladder

• Ward: Senior paediatric review within the hour for feeding failure plus tachypnoea; cardiology fellow paging if known severe AV valve regurgitation.
• Critical care: PICU referral when inotrope or ventilatory support is contemplated, or when shock index remains abnormal after initial resuscitation.

Pre-operative / ambulatory

• Teach families to recognise tachypnoea versus benign newborn periodic breathing—provide written thresholds.
• Medicine safety: demonstrate metric syringe technique; label storage for digoxin where used.

Perioperative edges

• Ensure fasting instructions are co-signed by anaesthesia; reconcile electrolyte panels morning of surgery.
• Document neurological and peripheral perfusion baselines pre-induction for later comparison.

Education & evaluation

• Use teach-back on wound care, caloric targets, and activity limits post-discharge.
• Measure effectiveness by weight velocity, caregiver-reported feeding endurance, and unplanned ED visits—not single-point weights.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of partial / complete atrioventricular septal defects (AVSD), heart-failure stabilisation, neonatal / paediatric surgical repair timing and the pulmonary-hypertension / Eisenmenger red flags.